[Cisapride related movement disorders]

R Lucena1, L Monteiro, A Melo

  • 1Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil.

Jornal De Pediatria
|December 20, 2003
PubMed

Insights

Cisapride, a medication for gastroesophageal reflux disease, was linked to new-onset involuntary movements in an infant. Discontinuing cisapride led to the resolution of these concerning neurological symptoms.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Gastroesophageal reflux disease (GERD) is common in infants.
  • Cisapride has been used to manage GERD.
  • Adverse neurological events associated with cisapride are rare but significant.

Purpose of the Study:

  • To report a case of movement disorder in an infant treated with cisapride.
  • To highlight the potential neurological side effects of cisapride.

Main Methods:

  • A case report methodology was employed.
  • Detailed clinical observation and neurological examination were performed.
  • Exclusion of other potential etiologies (metabolic, toxic, infectious) was conducted.

Main Results:

  • An 8-month-old male infant developed repetitive hand and foot movements after initiating cisapride for GERD.
  • The movement disorder correlated with cisapride dosage.
  • Neurological evaluation revealed an absent parachute reflex.
  • Discontinuation of cisapride resulted in complete resolution of symptoms within 30 days.

Conclusions:

  • Cisapride can be associated with new-onset involuntary movements in infants.
  • Neurological symptoms such as seizures, somnolence, malaise, or involuntary movements warrant consideration for cisapride discontinuation.
  • Careful monitoring for adverse neurological effects is crucial in patients receiving cisapride.

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...